| Bannwarth
A. Zur Klinik und Pathogenese der „chronischen lymphocytären
Meningitis“. Arch Psychiatr Nervenkr 1944; 117: 161-185. |
Baradaran-Dilmaghani
R, Stanek G. in vitro susceptibility of thirty
Borrelia strains from various sources against eight antimicrobial
chemotherapeutics. Infection. 1996; 24:60-63. |
| Blaschitz
M, Narodoslavsky-Gföller M, Kanzler M, Walochnik J
& Stanek G. Borrelia burgdorferi sensu lato genospecies
in questing Ixodes ricinus ticks in Austria. Int
J Med Microbiol 2008;298 S1: 168-176. |
| Buchwald
A. Ein Fall von diffuser idiopathischer Haut-Atrophie. Arch
Dermatol Syph 1883; 10:553-556. |
| Cetin
E, Sotoudeh M, Auer H, Stanek G. Paradigm Burgenland: risk
of Borrelia burgdorferi sensu lato infection indicated by
variable seroprevalence rates in hunters. Wien Klin Wochenschr.
2006, 118:677-81. |
| Douglas
JM Jr. Penicillin treatment of syphilis: clearing away the
shadow on the land. JAMA. 2009; 301:769-771. |
Ehrmann
S, Falkenstein F. Über Dermatitis atrophicans und ihre
pseudo-sklero-dermatischen Formen. Arch Dermatol Syph 1925;
149:142-175. |
| Garin
C, Bujadoux R. Paralysie par les tiques. J Med Lyon 1922;
71:765-767. |
| Hellerström
S. Erythema chronicum migrans Afzelii. Acta Derm Venereol
(Stockh) 1930; 11:315-321. |
| Herxheimer
K, Hartmann K. Über Acrodermatitis chronica atrophicans.
Arch Dermatol Syph 1902; 61:255-300. |
| Hollström
E. Successful treatment of erythema migrans Afzelius. Acta
Derm Venereol (Stockh) 1951; 31:235-243. |
| Hopf
HC. Acrodermatitis chronica atrophicans (Herxheimer) und
Nervensystem. (Monographien
aus dem Gesamtgebiete der Neurologie und Psychiatrie, Vol
114) 1966 Springer, Berlin Heidelberg New York. |
| Hörstrup
P, Ackermann R. Durch Zecken übertragene Meningopolyneuritis
(Garin-Bujadoux, Bannwarth). Fortschr Neurol Psychiatr 1973;
41:583-606. |
| Hunfeld
KP et al. New colorimetric microdilution method for in
vitro susceptibility testing of Borrelia
burgdorferi against antimicrobial substances.
Eur J Clin Microbiol Infect Dis 2000; 19:27-32. |
| Hunfeld
KP, Brade V. Antimicrobial susceptibility of Borrelia
burgdorferi sensu lato: what we know, what
we don't know, and what we need to know. Wien Klin Wochenschr.
2006; 118:659-668. |
| Hunfeld
KP, Rödel R, Wichelhaus TA. In vitro activity of eight
oral cephalosporins against Borrelia burgdorferi.
Int J Antimicrob Agents. 2003; 21:313-8. |
| Hunfeld
KP, Ruzic-Sabljic E, Norris DE, Kraiczy P, Strle F. in
vitro susceptibility testing of Borrelia
burgdorferi sensu lato isolates cultured
from patients with erythema migrans before and after antimicrobial
chemotherapy. Antimicrob Agents Chemother. 2005; 49:1294-301. |
| Jessner
M. Zur Kenntnis der Acrodermatitis chronica atrophicans.
Arch Dermatol Syph 1921; 134:478-487. |
| Jessner
M, Loewenstamm A. Bericht über 66 Fälle von Acrodermatitis
chronica atrophicans. Dermatol Wochenschr 1924; 79:1169-1177. |
| Kaiser
R, Fingerle V. Neuroborreliosis. Nervenarzt. 2009; 80:1239-1251. |
| Karlsson
M., S. Hammers-Berggren, MD, L. Lindquist, G. Stiernstedt,
and B. Svenungsson. Comparison of intravenous penicillin
G and oral doxycycline for treatment of Lyme neuroborreliosis.
Neurology 1994; 44:1203-1207. |
| Krause
A, Fingerle V. Lyme borreliosis. Z Rheumatol. 2009; 68:239-252. |
| Kristoferitsch
W. Neuropathien bei Lyme-Borreliose. 1989 Springer, Wien
New York. Kristoferitsch W et al. Meningopolyneuritis (Garin-Bujadoux,
Bannwarth). Clinical aspects and laboratory findings. Nervenarzt
1983; 12: 640-646. |
| Kristoferitsch
W et al. High-dose penicillin therapy in meningopolyneuritis
Garin-Bujadoux-Bannwarth. Clinical and cerebro-spinal fluid
data. Zentralbl Bakteriol Mikrobiol Hyg 1987; 263:357-364. |
| Lipschütz
B. Über eine seltene Erythemform (Erythema chronicum
migrans). Arch Dermatol Syph 1913; 118:349-356. |
| Ljøstad
U, Mygland A. Remaining complaints 1 year after treatment
for acute Lyme neuroborreliosis; frequency, pattern and
risk factors. Eur J Neurol. 2009 Jul 23. [Epub ahead of
print. |
Ljøstad
U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A,
Mygland A. Oral doxycycline versus intravenous ceftriaxone
for European Lyme neuroborreliosis: a multicentre, non-inferiority,
double-blind, randomised trial. Lancet Neurol. 2008; 7:690-
695. |
| Morgenstern
K, Baljer G, Norris DE, Kraiczy P, Hanssen-Hübner C,
Hunfeld KP. in vitro susceptibility of Borrelia
spielmanii to antimicrobial agents commonly used for
treatment of Lyme disease. Antimicrob Agents Chemother.
2009; 53:1281-1284. |
| Radda
A, Burger I, Stanek G, Wewalka G. Austrian hard ticks as
vectors of Borrelia burgdorferi. Zbl Bakt Mikrobiol Hyg
A. 1986; 263:79-82. |
| Rödel
R, Freyer A, Bittner T, Schäfer V, Hunfeld KP. in
vitro activities of faropenem, ertapenem, imipenem
and meropenem against Borrelia burgdorferi
s.l. Int J Antimicrob Agents. 2007; 30:83-86. |
| Stanek
G, Strle F. Lyme borreliosis. Lancet. 2003; 362:1639-1647. |
| Stanek
G. Zur Epidemiologie der Lyme-Borreliose in Österreich
& Borreliose-Update 2008. Antibiotika Monitor Heft 2/3
aus 2008. |
| Stanek
G, Strle F. Lyme borreliosis: a European perspective on
diagnosis and clinical management. Curr Opin Infect Dis.
2009; 22:450-454. |
| Thyresson
N (1949) The penicillin treatment of acrodermatitis chronica
atrophicans (Herxheimer). Acta Derm Venereol (Stockh) 29:572-621. |
| Weber
K (1974) Erythema-chronicummigrans-Meningitis – eine
bakterielle Infektionskrankheit? Munch Med Wochenschr 116:1993-1998. |
